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Background
In 2007, less than 1% of the children born in France to HIV-
1 positive mothers are infected, as preventive HAART is
used. A high HIV-1 genetic diversity is observed, with nearly
60% of non-B subtypes, especially among women of Afri-
can origin. The objective of this study was to evaluate new
molecular technologies developed for HIV-1 diagnosis in
babies, using HIV-DNA and HIV-RNA detection in babies'
blood samples.
Material and methods
All infants born between May 2005 and April 2007, with
samples sent to Necker's Virology Laboratory, were
included in this study. Early diagnosis was based on viral
detection on samples taken in the first days of life, at 1, 3
and 6 months. A new protocol using Real Time PCR tech-
nology (LTR) was developed to facilitate HIV diagnosis on
whole blood that used HIV-DNA quantification in cells
(ANRS AC 11/12) (1µg total DNA per amplification; detec-
tion cut-off value 1.6 log HIVcopies/106 leukocytes). HIV-
RNA was quantified in plasma (Roche Cobas Amplicor and
Cobas Taqman).
Results
1135 infants were included in this sub-study of the
National EPF cohort, with 3133 samples received in the
Laboratory during the study period. The specificity of HIV-
DNA and HIV-RNA real time PCR assays was estimated at
100% and 98% respectively; 1126 children were not
infected, nine were infected as they presented with positive
results on two consecutive samples; five of them were in
utero infected (1st sample at birth: median HIV-
DNA=2.2log copies/106 leukocytes [min<1.6log,
max:3.7log], median HIV-RNA=3.5log copies/mL
[min:1.8log, max:4.3log]), while four infants were intra-
partum infected: the first sample negative with both tech-
niques and the second one positive: median HIV-
DNA=2.85log [min:2.1log, max:3.7log], median HIV-
RNA=5.1log [min:1.6log, max:6.4log].
Six patients had low viral levels (8 samples with HIV-
DNA<2.5log; and 8 samples with HIV-RNA<4.0log). Lastly,
two infants had discordant results, one with HIV-DNA neg-
ative and HIV-RNA at 1.8 log; inversely, the 2nd infant with
HIV-RNA negative, while HIV-DNA was at 2.0 log, underly-
ing the necessity to perform both assays in the context of
preventive HAART.
Conclusions
Despite HAART, few cases of infection are still occurring in
newborns of northern countries. The HIV-1 primary infec-
tion occurs in infants under antiretroviral pressure, reduc-
ing viral replication's level, so making the diagnosis more
difficult than previously. Our results show that, in the con-
text of preventive HAART, very sensitive and specific tech-
niques are necessary to detect very low viral levels before 60
days of life, both in plasma and PBMC of HIV-1 infected
infants.
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